TP53 and neoplasm: The multivariable Cox model shows that detection of KRAS or TP53 mutations in cfDNA were associated with survival outcome independent of tumor stage, age, and sex (medians of 10.5 vs 18 months, p = 0.019, Tables 1 and 2; Kaplan Meier curves presented in Fig. 2).